Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E-coli during Chronic Infection

被引:50
作者
Conover, Matt S. [1 ,2 ]
Ruer, Segolene [3 ,4 ]
Taganna, Joemar [3 ,4 ]
Kalas, Vasilios [1 ,2 ]
De Greve, Henri [3 ,4 ]
Pinkner, Jerome S. [1 ,2 ]
Dodson, Karen W. [1 ,2 ]
Remaut, Han [3 ,4 ]
Hultgren, Scott J. [1 ,2 ]
机构
[1] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA
[3] VIB, Struct Biol Res Ctr, Struct & Mol Microbiol, Pl Laan 2, B-1050 Brussels, Belgium
[4] Vrije Univ Brussel, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium
关键词
URINARY-TRACT-INFECTIONS; INTRACELLULAR BACTERIAL COMMUNITIES; BLADDER INFECTION; EPITHELIAL-CELLS; MOUSE STRAINS; X-RAY; TYPE-1; BINDING; PERSISTENT; COMPLEX;
D O I
10.1016/j.chom.2016.08.013
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Uropathogenic E. coli (UPEC) is the dominant cause of urinary tract infections, clinically described as cystitis. UPEC express CUP pili, which are extracellular fibers tipped with adhesins that bind mucosal surfaces of the urinary tract. Here we identify the role of the F9/Yde/Fml pilus for UPEC persistence in the inflamed urothelium. The Fml adhesin FmlH binds galactose beta 1-3 N-acetylgalactosamine found in core-1 and-2 O-glycans. Deletion of fmlH had no effect on UPEC virulence in an acute mouse model of cystitis. However, FmlH provided a fitness advantage during chronic cystitis, which is manifested as persistent bacteriuria, high bladder bacterial burdens, and chronic inflammation. In situ binding confirmed that FmlH bound avidly to the inflamed, but not the naive bladder. In accordance with its pathogenic profile, vaccination with FmlH significantly protected mice from chronic cystitis. Thus, UPEC employ separate CUP pili to adapt to the rapidly changing niche during bladder infection.
引用
收藏
页码:482 / 492
页数:11
相关论文
共 60 条
  • [1] Intracellular bacterial biofilm-like pods in urinary tract infections
    Anderson, GG
    Palermo, JJ
    Schilling, JD
    Roth, R
    Heuser, J
    Hultgren, SJ
    [J]. SCIENCE, 2003, 301 (5629) : 105 - 107
  • [2] Tamm-Horsfall protein knockout mice are more prone to urinary tract infection
    Bates, JM
    Raffi, HM
    Prasadan, K
    Mascarenhas, R
    Laszik, Z
    Maeda, N
    Hultgren, SJ
    Kumar, S
    [J]. KIDNEY INTERNATIONAL, 2004, 65 (03) : 791 - 797
  • [3] Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
    Boucher, Helen W.
    Talbot, George H.
    Bradley, John S.
    Edwards, John E., Jr.
    Gilbert, David
    Rice, Louis B.
    Scheld, Michael
    Spellberg, Brad
    Bartlett, John
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) : 1 - 12
  • [4] ESTABLISHED CELL LINE OF URINARY-BLADDER CARCINOMA (T-24) CONTAINING TUMOR-SPECIFIC ANTIGEN
    BUBENIK, J
    BARESOVA, M
    VIKLICKY, V
    JAKOUBKOVA, J
    SAINEROVA, H
    DONNER, J
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1973, 11 (03) : 765 - 773
  • [5] The role of fluoroquinolones in the management of urinary tract infections in areas with high rates of fluoroquinolone-resistant uropathogens
    Chen, Y. -H.
    Ko, W. -C.
    Hsueh, P. -R.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (08) : 1699 - 1704
  • [6] X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli
    Choudhury, D
    Thompson, A
    Stojanoff, V
    Langermann, S
    Pinkner, J
    Hultgren, SJ
    Knight, SD
    [J]. SCIENCE, 1999, 285 (5430) : 1061 - 1066
  • [7] Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112
  • [8] Treatment and Prevention of Urinary Tract Infection with Orally Active FimH Inhibitors
    Cusumano, Corinne K.
    Pinkner, Jerome S.
    Han, Zhenfu
    Greene, Sarah E.
    Ford, Bradley A.
    Crowley, Jan R.
    Henderson, Jeffrey P.
    Janetka, James W.
    Hultgren, Scott J.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (109)
  • [9] Prospective Cohort Study of Microbial and Inflammatory Events Immediately Preceding Escherichia coli Recurrent Urinary Tract Infection in Women
    Czaja, C. A.
    Stamm, W. E.
    Stapleton, A. E.
    Roberts, P. L.
    Hawn, T. R.
    Scholes, D.
    Samadpour, M.
    Hultgren, S. J.
    Hooton, T. M.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (04) : 528 - 536
  • [10] Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli
    Eto, Danelle S.
    Jones, Tiffani A.
    Sundsbak, Jamie L.
    Mulvey, Matthew A.
    [J]. PLOS PATHOGENS, 2007, 3 (07) : 949 - 961